Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

PURPOSE: Adoptive immunotherapy using tumor-infiltrating lymphocytes represents an effective cancer treatment for patients with metastatic melanoma. The NY-ESO-1 cancer/testis antigen, which is expressed in 80% of patients with synovial cell sarcoma and approximately 25% of patients with melanoma an...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Robbins, Paul F., Morgan, Richard A., Feldman, Steven A., Yang, James C., Sherry, Richard M., Dudley, Mark E., Wunderlich, John R., Nahvi, Azam V., Helman, Lee J., Mackall, Crystal L., Kammula, Udai S., Hughes, Marybeth S., Restifo, Nicholas P., Raffeld, Mark, Lee, Chyi-Chia Richard, Levy, Catherine L., Li, Yong F., El-Gamil, Mona, Schwarz, Susan L., Laurencot, Carolyn, Rosenberg, Steven A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2011
Soggetti:
Original Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3068063/
https://ncbi.nlm.nih.gov/pubmed/21282551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.32.2537
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi